These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22884215)

  • 1. Consistency of symptomatic dimensions of schizophrenia over 20 years.
    Cichocki L; Cechnicki A; Polczyk R
    Psychiatry Res; 2012 Dec; 200(2-3):115-9. PubMed ID: 22884215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Consistency of symptomatic dimensions of schizophrenia in a 12 year follow up study].
    Cechnicki A; Cichocki Ł; Franczyk-Glita J
    Psychiatr Pol; 2010; 44(2):185-96. PubMed ID: 20677438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
    Loas G; Noisette C; Legrand A; Delahousse J
    Encephale; 1997; 23(1):10-8. PubMed ID: 9172962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of the brief psychiatric rating scale factor structure.
    Shafer A
    Psychol Assess; 2005 Sep; 17(3):324-35. PubMed ID: 16262458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of the Brief Psychiatric Rating Scale - Expanded (BPRS-E) structure and arguments for a new version.
    Dazzi F; Shafer A; Lauriola M
    J Psychiatr Res; 2016 Oct; 81():140-51. PubMed ID: 27451107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Psychometric properties of PANSS (Positive and Negative Syndrome Scale) in the French version in a sample of schizophrenic patients].
    Lançon C; Auquier P; Llorca PM; Martinez JL; Bougerol T; Scotto JC
    Encephale; 1997; 23(1):1-9. PubMed ID: 9172961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The psychopathological factors of refractory schizophrenia.
    Alves TM; Pereira JC; Elkis H
    Braz J Psychiatry; 2005 Jun; 27(2):108-12. PubMed ID: 15962134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical dimensions of auditory hallucinations in schizophrenic disorders.
    Oulis P; Gournellis R; Konstantakopoulos G; Matsoukas T; Michalopoulou PG; Soldatos C; Lykouras L
    Compr Psychiatry; 2007; 48(4):337-42. PubMed ID: 17560954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective longitudinal 10-year study of schizophrenia's three major factors and depression.
    Marengo J; Harrow M; Herbener ES; Sands J
    Psychiatry Res; 2000 Dec; 97(1):61-77. PubMed ID: 11104858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Negative symptoms, depression, anxiety and alexithymia in DSM III-R schizophrenic patients].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(4):267-72. PubMed ID: 9417392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between exploratory eye movement dysfunction and clinical symptoms in schizophrenia.
    Suzuki M; Takahashi S; Matsushima E; Tsunoda M; Kurachi M; Okada T; Hayashi T; Ishii Y; Morita K; Maeda H; Katayama S; Otsuka T; Hirayasu Y; Sekine M; Okubo Y; Motoshita M; Ohta K; Uchiyama M; Kojima T
    Psychiatry Clin Neurosci; 2012 Apr; 66(3):187-94. PubMed ID: 22369367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of mood and affect in schizophrenic inpatients.
    Craig TJ; Richardson MA; Pass R; Bregman Z
    Am J Psychiatry; 1985 Nov; 142(11):1272-7. PubMed ID: 4061685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fifteen-year follow-up of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition depressive disorders: the prognostic significance of psychotic features.
    Jäger M; Bottlender R; Strauss A; Möller HJ
    Compr Psychiatry; 2005; 46(5):322-7. PubMed ID: 16122531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familiality in a five-factor model of schizophrenia psychopathology: findings from a 16-month follow-up study.
    Ritsner M; Ratner Y; Gibel A; Weizman R
    Psychiatry Res; 2005 Sep; 136(2-3):173-9. PubMed ID: 16098602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prodromal symptoms in schizophrenic relapse: A descriptive and comparative study].
    Bouhlel S; Jones Y; Khelifa E; Msolly M; Melki W; El-Hechmi Z
    Encephale; 2012 Oct; 38(5):397-403. PubMed ID: 23062453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The stability of negative syndrome, persistent negative syndrome and deficit syndrome in a twenty-year follow-up study of schizophrenia patients.
    Kalisz A; Cechnicki A
    Psychiatry Res; 2016 Apr; 238():236-241. PubMed ID: 27086239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis abuse and severity of psychotic and affective disorders in Israeli psychiatric inpatients.
    Katz G; Durst R; Shufman E; Bar-Hamburger R; Grunhaus L
    Compr Psychiatry; 2010; 51(1):37-41. PubMed ID: 19932824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability in schizophrenia symptoms over time: findings from the Mount Sinai Pilgrim Psychiatric Center Longitudinal Study.
    Reichenberg A; Rieckmann N; Harvey PD
    J Abnorm Psychol; 2005 Aug; 114(3):363-72. PubMed ID: 16117573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.